Free Trial

TG Therapeutics (TGTX) Insider Trading & Ownership

TG Therapeutics logo
$31.15 +0.83 (+2.74%)
(As of 11/20/2024 ET)

TG Therapeutics (NASDAQ:TGTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$1.65 M
Get TGTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling TG Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TGTX Insider Buying and Selling by Quarter

TG Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/11/2024Sagar LonialDirectorSell5,000$30.44$152,200.00  
3/12/2024Laurence N CharneyDirectorSell22,000$15.97$351,340.00  
1/5/2024Laurence N CharneyDirectorSell17,500$19.03$333,025.00  
1/3/2024Sean A PowerCFOSell47,867$16.91$809,430.97  
(Data available from 1/1/2013 forward)

TGTX Insider Trading Activity - Frequently Asked Questions

10.50% of TG Therapeutics stock is owned by insiders. Learn more on TGTX's insider holdings.

The following insiders have purchased TGTX shares in the last 24 months: Michael S Weiss ($1,013,000.00), and Yann Echelard ($95,760.00).

Insiders have purchased a total of 109,000 TGTX shares in the last 24 months for a total of $1,108,760.00 bought.

The following insiders have sold TGTX shares in the last 24 months: Laurence N Charney ($1,017,365.00), Sagar Lonial ($966,737.98), and Sean A Power ($2,775,805.87).

Insiders have sold a total of 230,868 TG Therapeutics shares in the last 24 months for a total of $4,759,908.85 sold.

TG Therapeutics Key Executives



This page (NASDAQ:TGTX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners